Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP89277.RAklCDKyBfephcfKXCHPHL-K1JLnf_Jx-VYX35u_uySOM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP89277.RAklCDKyBfephcfKXCHPHL-K1JLnf_Jx-VYX35u_uySOM130_assertion type Assertion NP89277.RAklCDKyBfephcfKXCHPHL-K1JLnf_Jx-VYX35u_uySOM130_head.
- NP89277.RAklCDKyBfephcfKXCHPHL-K1JLnf_Jx-VYX35u_uySOM130_assertion description "[Here, we hypothesize that variation in NFE2L2 and KEAP1, the genes encoding the two major regulators of the phase II response, may affect the risk of Parkinson's disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP89277.RAklCDKyBfephcfKXCHPHL-K1JLnf_Jx-VYX35u_uySOM130_provenance.
- NP89277.RAklCDKyBfephcfKXCHPHL-K1JLnf_Jx-VYX35u_uySOM130_assertion evidence source_evidence_literature NP89277.RAklCDKyBfephcfKXCHPHL-K1JLnf_Jx-VYX35u_uySOM130_provenance.
- NP89277.RAklCDKyBfephcfKXCHPHL-K1JLnf_Jx-VYX35u_uySOM130_assertion SIO_000772 20196834 NP89277.RAklCDKyBfephcfKXCHPHL-K1JLnf_Jx-VYX35u_uySOM130_provenance.
- NP89277.RAklCDKyBfephcfKXCHPHL-K1JLnf_Jx-VYX35u_uySOM130_assertion wasDerivedFrom gad-20130706 NP89277.RAklCDKyBfephcfKXCHPHL-K1JLnf_Jx-VYX35u_uySOM130_provenance.
- NP89277.RAklCDKyBfephcfKXCHPHL-K1JLnf_Jx-VYX35u_uySOM130_assertion wasGeneratedBy ECO_0000203 NP89277.RAklCDKyBfephcfKXCHPHL-K1JLnf_Jx-VYX35u_uySOM130_provenance.